Bg Medicine Inc (BGMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,303 | -8,064 | -15,849 | -23,769 | -17,582 |
| Depreciation Amortization | 87 | 131 | 165 | 273 | 420 |
| Accounts receivable | -158 | 145 | 76 | -280 | 671 |
| Other Working Capital | -24 | -1,127 | -1,367 | -385 | 199 |
| Other Operating Activity | 1,731 | 748 | 1,687 | 2,828 | 1,326 |
| Operating Cash Flow | $-3,667 | $-8,167 | $-15,288 | $-21,333 | $-14,966 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 13 | N/A | -32 | -85 | -93 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -16,139 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 16,139 |
| Investing Cash Flow | $13 | $N/A | $-32 | $-85 | $-93 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 500 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | 10,000 | 0 |
| Debt Repayment | -2,984 | -4,480 | -2,533 | 0 | -100 |
| Common Stock Issued | 2,500 | 9,262 | 13,107 | 586 | 37,903 |
| Other Financing Activity | 1,040 | -243 | -289 | -256 | -1,295 |
| Financing Cash Flow | $1,056 | $4,539 | $10,285 | $10,330 | $36,508 |
| Beginning Cash Position | 4,123 | 7,751 | 12,786 | 23,874 | 2,425 |
| End Cash Position | 1,525 | 4,123 | 7,751 | 12,786 | 23,874 |
| Net Cash Flow | $-2,598 | $-3,628 | $-5,035 | $-11,088 | $21,449 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,667 | -8,167 | -15,288 | -21,333 | -14,966 |
| Capital Expenditure | N/A | N/A | -132 | -85 | -93 |
| Free Cash Flow | -3,667 | -8,167 | -15,420 | -21,418 | -15,059 |